The application of engineered liver tissues for novel drug discovery.

The application of engineered liver tissues for novel drug discovery.

Item
http://www.wikidata.org/entity/Q38404573
Models and methods for in vitro testing of hepatic gap junctional communicationStrategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchLong-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes.Adverse Outcome Pathways and Drug-Induced Liver Injury Testing.3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip.Phenotypic Screens in Antimalarial Drug Discovery.Engineered Liver Platforms for Different Phases of Drug Development.Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease.Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.Organ-on-a-chip devices advance to market.In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery.Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform.Non-alcoholic fatty liver disease (NAFLD) models in drug discovery.
P2860

The application of engineered liver tissues for novel drug discovery.

Item
http://www.wikidata.org/entity/Q38404573
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The application of engineered liver tissues for novel drug discovery.
@en
type
label
The application of engineered liver tissues for novel drug discovery.
@en
prefLabel
The application of engineered liver tissues for novel drug discovery.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
The application of engineered liver tissues for novel drug discovery.
@en
P2093
P2860
P304
P31
P356
10.1517/17460441.2015.1032241
P407
P433
P478
P577
P5875
P698